Retrospective Comparisons of the Efficacy and Safety of Variable dosing of Midazolam with and without Meperidine for Management of Varying Levels of Anxiety of Pediatric Dental Patients: 35 years of Sedation Experience

Purpose: This retrospective study compares the efficacy and safety of variable dosing of Midazolam (Mid) with and without Meperidine (Mep) combinations for managing varying levels of anxiety and uncooperative behavior of young pediatric dental patients over a thirty-five-year period. Study design: Reviews of the sedation logs of 1,785 sedation visits are compared with emphasis on what dosing proves both safe and effective for differing levels of challenging pediatric behavior. Variable dosing of midazolam with and without meperidine which spanned low-end, mid-range, and upper-end were judged making use of a pragmatic approach which defined sedation success as optimal, adequate, inadequate, or over-dosage. Behavioral and physiologic assessment was included with attention to readily observable analysis of the extent to which need for physical restraint occurred to control interfering behavior. Assessment of arousal levels requiring stimulation along with the frequency of alterations in oxygen de-saturation and adverse reactions were included as indications of safety. Results: Where Mep was used, success rates were consistently higher; working times were significantly prolonged and greater control was provided to avoid adverse reactions by virtue of reversal capability for both agents. Conclusions: Predictability and working time of Midazolam was enhanced by combination with narcotic for all levels of patient anxiety. Dosages of 0.7-1.0 mg/kg Mid combined with 1.0-1.5 mg/kg Mep offers the most effective and safe results to overcome need for restraint for moderate and severe levels of anxiety, respectively

Sedation; Midazolam; Meperidine

1. Wilson, S. Houpt, MI Project USAP 2010: Use of Sedative Agents in Pediatric Dentistry–a 25 year Follow-up Survey, Ped Dent ,2016;38(2); 127-133.

2. Wilson, S, Nathan, JE. A Survey Study of Sedation Training in advanced pediatric dentistry programs: Thoughts of Program Directors and Students, Ped Dent , 2011 ;33:353-360.

3. Loeffler, PM, Oral benzodiazepines and conscious sedation J Oral and Maxillofacial Surg , 1990; 50:20-28.

4. Sams, DR, Cook, EW, Jackson, JG, Roebuck, BL, Behavioral assessments of two drug combinations for oral sedation, Ped Dent, 1993;15:186-190.

5. Abrams, R, Morrison, JE, et al Safety and effectiveness of intranasal administration of sedative medications, (ketamine, midazolam, or sufentanil for urgent brief pediatric dental procedures, Anesth Progress, 1993;40:63-66.

6. Silver, T, Wilson, C, Webb, M, Evaluation of two dosages of oral midazolam as a conscious sedation for physically and neurologically compromised dental patients, Ped Dent , 1994;16:350-359.

7. Fukata, O, Braham, R, Yanase, H, Kurosu, K The sedative effects of intranasal midazolam administration in the treatment of patients with mental disabilities, J Clin Ped Dent, 1994; 18:259-265.

8. Fukata, O, et al Intranasal administration of midazolam: pharmacokinetic and pharmacodynamic properties and sedative potential, J Dent Child , 1997;64-89—98.

9. Hartgraves, PM, Primosch, RE An evaluation of oral and nasal midazolam for pediatric dental sedation, J Dent Child, 1997; 61:175-181.

10. Melamed, SF Sedation: A Guide to Patient Management, St. Louis: Mosby, 1995.

11. Haas, DA, Nenninger, SA, et al A pilot study of the efficacy of oral midazolam for sedation in pediatric dental patients, Anesth Progress, 1996; 43:1-8.

12. Shapira, J, Holan, G et al The effectiveness of midazolam and hydroxyzine as sedative agents for young pediatric dental patients, J Dent Child , 1996; 63:421-425.

13. Smith, BM, Cutilli, BJ, Saunders, W Oral midazolam: pediatric conscious sedation, Compendium Continuing Educ in Dent , 1998; 19:586-588.

14. Wilson, S, Easton J, Lamb,K, Orchardson, R, Casamassimo, P A retrospective study of chloral hydrate, meperidine, hydroxyzine and midazolam regimens used to sedate children for dental care, Ped Dent , 2000; 22:107-112.

15. Milnes, AR, Dip, et al Intravenous sedation in pediatric dentistry using Midazolam, Nalbuphine, and Droperidol, Ped Dent, 2000; 22:113-119.

16. Shannon, M Alvers G et al, Safety and efficacy of flumazenil in the reversal of benzodiazepine-induced conscious sedation, J Pediatrics , 1997;131:582-586.

17. Nathan, JE, Vargas, KG Oral midazolam with and without meperidine for management of the difficult young pediatric dental patient : a retrospective study, Ped Dent , 2002; 24:129-138.

18. Reference Manual, American Academy of Pediatric Dentistry, Ped Dent 31(6), 294, 2009-10. 19. Blumer, JL, Clinical Pharmacology of midazolam in infants and children, Clin Pharmacokin , 1998; 35:37-47.

20. Marshall, J, Rodarte, A, Blumer, J et al; Pediatric Pharmacodynamics of midazolam oral syrup, Ped , 2000;40:578-589.

21. Adair, SM et al, Survey of behavior management teaching in pediatric dentistry advanced education programs, Ped Dent , 2004; 26:151-158.

22. Nathan, JE, Management of the Difficult Child: A Survey of pediatric dentists’ use of restraints, sedation, and general anesthesia, J Dent Child, 1989;56:293-301.

23. Nathan, JE and West, MS Comparison of Chloral Hydrate-hydroxyzine with and without meperidine for management of the difficult Pediatric patient J Dent Child , 1987; 54:437-444.

24. Hasty,MF, Vann, WF, Jr, Dilley, DC, and Anderson, JA Conscious Sedation of Pediatric Dental Patients: An investigation of Chloral Hydratehydroxyzine with and without Meperidine, Pediatrics,1991; 13(1)10-19.

25. Nathan, JE, The Disappearance of Chloral Hydrate as an effective sedation for management of challenging child dental behavior: An inappropriate and unfortunate outcome: J Pharmacol and Clin Research, 2018; 6(1)1-4.

26. Bahal-O’Mara, N, et al, Sedation with Meperidine and midazolam in pediatric patients undergoing endoscopy, Europ J Clin Pharmacol, 1994; 47:319-323.

27. Marx, CM, Stein, J, et al, Ketamine-Midazolam vs Midazolam-Meperidine for painful procedures in pediatric oncology patients, J Clin Oncology, 1997;15:94-102.

28. Lee, J, Ryu, SH, et al Midazolam with meperidine and dexmetetomidine vs midazolam and meperidine for sedation during ERCP, Endoscopy ,2014; 46(4)291-298.

29. Sheroan, MMN, Dilley, DC, Vann, WF,Jr., A prospective study of two sedation regimens in children: Chloral hydrate-hydroxyzine-meperidine vs midazolam-meperidine and Hydroxyzine, Anesthes Prog ,2006; 53(3)83-90,.

30. Musial, KM , Wilson, S, Priesch,J Weaver, J Comparison of the Efficacy of Oral Midazolam alone vs Midazolam and Meperidine in the Pediatric Dental Patient, Ped Dent, 2003; 25:468-474.

31. Vargas, KG, Nathan, JE, Quian, Kupietsky, A, Use of restraint and management style as parameters for defining sedation success, Ped Dent, 2007; 29(3) 220-227.

32. Murphy, MG, Fields, HW, Machen B, Parental Acceptance of pediatric dentistry behavior management techniques, Ped Dent, 1984; 13:1516:193-198.

33. Lawrence, SM, McTigue, DJ, Parental Attitudes toward Behavior Management Attitudes Ped Dent , 1991; 13:151-156.

34. Cassamasimo, PS, Wilson ,S Gross, L, Effects of Changing U.S. Parenting Styles on Dental Practices: Perceptions of Diplomates of the American Board of Pediatric Dentistry, Ped Dent , 2002; 24: 18-22.

35. Eaton, JJ, et al, Attitudes of contemporary parents towards behavior management techniques used in pediatric dentistry, Ped Dent, 2005; 27:107-113.

36. Vargas, KG, Nathan, JE, Quian, J, Kupietsky, A, A use of restraint and management style as parameters for defining sedation success, Ped Dent, 2007; 29(3) 220-227.

37. Nathan, JE, Historical nd contemporary use of Chloral hydrate as a sedative-hypnotic – and alternatives for management of moderate to severe childhood Dental anxiety and uncooperative behavior, J of Pharmacolog and Clinical Res, 2016; 1(4)1-7.

38. Mather, LE, Tucker, GT, Systemic availability of orally administered meperidine, Clin Pharmac Ther , 1976 ; 20:535-540.

39. Frankl. SN, et al, Behavioral Rating Scale, J Dent Child, 1962 29; 150-163.

40. Unkel, JH, Cruise, C, et al, A retrospective evaluation of the safety profile of Dexmedetomidine plus nitrous oxide for pediatric dental sedation, Ped Dent, 2021, 43(2) 120-132.